SAGE meeting of 9 - 11 November 2010
Background documents
Report from IVB director
-
Meeting of the Strategic Advisory Group of Experts on immunization, April 2010 – conclusions and recommendations. Meeting report. WER 2010: 85, 197–212.
pdf, 318kb -
Updated tracking record of recommendations and action points. World Health Organization.
pdf, 124kb -
Executive Board - 128th session - Item 4.5. Fifth Draft 15 October 2010. Global immunization vision and strategy. Report by the secretariat.
pdf, 139kb -
Changing epidemiology of pneumococcal serotypes after introduction of conjugate vaccine: July 2010 report. WER 2010: 85, 434-3.
pdf, 446kb -
WHO immunization work: 2008-09 highlights. WHO Publication, 2010.
pdf, 669kb
Report from GAVI Alliance secretariat
Regional priorities, major policy and implementation issues
-
AMR: CD50.R5 (Eng.) Resolution: Strengthening Immunization Programs. WHO Pan American Health Organization. 50th Directing Council. 62nd Session of the regional committee 2010
pdf, 120kb -
AMR: CD50/14 (Eng.) Concept paper: Strengthening Immunization Programs. WHO Pan American Health Organization. 50th Directing Council. 62nd Session of the regional committee 2010.
pdf, 2.30Mb -
EUR: 10th meeting of the European Technical Advisory Group of Experts on Immunization (ETAGE)
pdf, 201kb -
EUR: Report of the 23rd Meeting of the European Regional Certification Commission for Poliomyelitis Eradication, Denmark, June 2010
pdf, 632kb -
EUR: EUR/RC60/R12 Resolution: Renewed commitment to elimination of measles and rubella and prevention of congenital rubella syndrome by 2015 and Sustained support for polio-free status in the WHO European Region. Regional Committee for Europe, 60th session
pdf, 99kb -
EUR: EUR/RC60/15, EUR/RC60 Conference Document 9: Renewed commitment to measles and rubella elimination and prevention of congenital rubella syndrome in the WHO European Region by 2015. Draft report.
pdf, 40kb -
WPR: 19th meeting of the Technical Advisory Group on Immunization and Vaccine Preventable Diseases in the Western Pacific Region. Philippines, 24-27 August 2010. Meeting report.
pdf, 164kb -
WPR: WPR/RC61.R7 Resolution: Vaccine Preventable Diseases: Measles Elimination, Hepatitis B Control and Poliomyelitis Eradication. WHO Regional Committee for the Western Pacific 2010
pdf, 64kb -
WPR/RC61/10 WHO Regional Office for the Western Pacific report: Vaccine Preventable Diseases: Measles Elimination, Hepatitis B Control and Poliomyelitis Eradication. 61st session of the WHO Regional Committee for the Western Pacific 2010.
pdf, 36kb
Reports from other Advisory Committees in Immunization
-
ECBS: WHO/BS/10. 2155. Expert Committee on Biological Standardization, 18 to 22 October 2010. Procedure for assessing the acceptability, in principle, of vaccines for purchase by United Nations agencies. World Health Organization 2010
pdf, 703kb -
GACVS: Global Advisory Committee on Vaccine Safety (GACVS), 16–17 June 2010. Meeting report. WER 2010: 85, 285–291.
pdf, 294kb -
GACVS: Pandemrix® vaccine and cases of narcolepsy. GACVS statement, 27 August 2010.
pdf, 46kb -
GACVS: Statement on Rotarix® and Rotateq® vaccines and intussusception. GACVS statement, 22 September 2010.
pdf, 52kb -
IPAC: Immunization Practices Advisory Committee (IPAC), 29 - 30 June 2010. Draft Meeting report and recommendations.
pdf, 251kb -
QUIVER: Executive Summary of the report on the WHO Quantitative Immunization and Vaccines Related Research (QUIVER) Advisory Committee Meeting Geneva, 5-7 October 2010.
pdf, 44kb
Typhoid vaccines: feed-back on regional implementation of SAGE recommendations
Seasonal influenza and H5N1 pandemic influenza vaccine
-
Pandemic (H1N1) 2009 vaccine deployment update – 27 September 2010
pdf, 51kb -
Strategic Advisory Group of Experts: recommendations on the use of licensed human H5N1 influenza vaccines in the interpandemic period. Meeting report. WER 2009: 84, 244–48.
pdf, 543kb -
Strategic Advisory Group of Experts on immunization. Working Group on H5N1 Influenza Vaccines. 27 September 2010, WHO HQ, Minutes.
pdf, 194kb -
Strategic Advisory Group of Experts on immunization. Working Group on Influenza Vaccines and Immunization. 11-12 October 2010, WHO Geneva. Minutes.
pdf, 221kb
Polio eradication
-
The Global Polio Eradication Initiative (GPEI) Strategic Plan 2010-2012. WHO Publication, May 2010.
pdf, 7.12Mb -
GPEI Strategic Plan 2010-2012. Quarterly progress report against milestones and process indicators. Report as at 1 October 2010.
pdf, 2.85Mb -
Teleconference of the SAGE IPV Working Group, September 29, 2010. Draft minutes.
pdf, 112kb -
Polio Vaccine for Routine Immunization. Regional Director, EMRO Cairo memo to IVB Director, WHO HQ on 3 June 2010.
pdf, 47kb -
Polio Vaccine for Routine Immunization. IVB Director, WHO HQ response to Regional Director, EMRO Cairo on 31 August 2010.
pdf, 41kb
Feasibility of measles eradication
Biological feasibility work
Programmatic feasibility reports - per region and including comprehensive epidemiological data.
-
AFRO: Measles pre-elimination & the programmatic feasibility of measles elimination in the African Region. September 2009
pdf, 489kb -
AMRO: Measles Elimination in the Americas and Feasibility of Global Measles Elimination, 2009
pdf, 167kb -
AMRO: Annex 1
pdf, 73kb -
AMRO: Annex 2
pdf, 1.13Mb -
AMRO: Annex 3
pdf, 192kb -
EMRO: Programmatic Feasibility of Measles Elimination. WHO Eastern Mediterranean Region, June 2010.
pdf, 941kb -
EURO: Programmatic Feasibility of Measles Elimination in WHO European Region, 2010.
pdf, 491kb -
EURO: Annexes 1-7 and 11
pdf, 598kb -
EURO: Annexes 8-9
pdf, 85kb -
SEARO: Programmatic Feasibility of Measles Elimination in South East Asia Region, 2010.
pdf, 675kb -
SEARO: Report of the Regional Consultation on Measles. WHO SEARO, New Delhi, India, 25–27 August 2009
pdf, 355kb -
SEARO: Measles and Rubella Fact Sheet SEAR 2008-2009
pdf, 2.09Mb -
SEARO: SEA/RC62/R3 South-East Asia Regional Efforts on Measles Elimination
pdf, 143kb -
WPRO: WPRO Feasibility Report
pdf, 825kb -
WPRO: Annex 1-2 - measles epidemiology
pdf, 41kb -
WPRO: Annex 2b: Measles Genotype Distribution, WPR 2006-2009
pdf, 327kb -
WPRO: Annex 2c: Measles genotypes, WPR, 1995-2009
pdf, 562kb -
WPRO: Annex 3 - funding 2003-09
pdf, 9kb -
WPRO: Annexes 4-7, 9-12 - v3
pdf, 244kb
Vaccine market analysis - draft report as presented to the SAGE at the April 2010 meeting
-
Is There Enough Vaccine to Eradicate Measles? An Integrated Analysis of Measles-Containing
pdf, 164kb
Impact on health systems
-
Measles eradication and health systems impacts: Evidence from six countries. Summary Report Draft 20 July 2010
pdf, 1.70Mb -
A Toolkit for Assessing the Impacts of Measles Eradication Activities on Immunization Services and Health Systems at Country Level. Data collected in 2009-2010
pdf, 1.11Mb
Economic analysis
-
Cost effectiveness of measles eradication. Final Report, 12 August 2010
pdf, 1.62Mb -
Economic Evaluation of Measles Eradication Study: Results for Six Countries and by Income Groups
pdf, 667kb -
Country appendices
pdf, 30.59Mb
Risk analysis - possibility of re-introduction of measles transmission post eradication
Stakeholders analysis
Comparative analysis
Immunization schedules: Update
-
Scott P et al. (2010): Systematic review of pneumococcal conjugate vaccine schedules: Executive summary of findings about reduced dose schedules. Summary for SAGE meeting, November 2010: preliminary data.
pdf, 880kb -
Melegaro A. et al. (2010): Using mathematical model to evaluate the impact of different PCV schedules: Preliminary results from the West Africa epidemiological scenario
pdf, 196kb
Low-middle-income countries: sustainable adoption and financing of new vaccines
Accessibility to affordable vaccines: WH0's role in supporting emerging vaccine manufacturers
-
Landscape Analysis: WHO’s Role in Supporting Emerging Vaccine Manufacturers
pdf, 1.03Mb -
Summaries of Complementary Presentations on Agenda Item: WHO’s Role in Supporting Emerging Vaccine Manufacturers
pdf, 111kb -
A novel initiative to increase access to adjuvants for developing countries vaccine manufacturers. N. Collin, presentation at the 3rd Meeting with International Partners for Influenza Vaccine Technology Transfer to DCVM, 2010 Vietnam
pdf, 1.17Mb -
Know-how transfer examples: Hib conjugate, influenza, polio. J. Hendriks, H. Kreeftenberg, presentation at the WHO/DCVMN Workshop on IPR and Vaccines, 2009 Japan
pdf, 10.01Mb -
Status of WHO Influenza Vaccine Technology Transfer Programme. L Palkonyay, presentation at the 3rd Meeting with International Partners for Influenza Vaccine Technology Transfer to DCVM, 2010 Vietnam
pdf, 634kb -
Call for Expressions of Interest in Developing Sabin -Inactivated Polio Vaccine (sIPV). World Health Organization 2010
pdf, 91kb - Kreeftenberg H. et al. (2006): Technology transfer of Sabin-IPV to new developing country markets. Biologicals: 34, 155-158
-
WHO Guiding Principles on Transfer of Technology. Draft for Comment. World Health Organization Working Document 2010
pdf, 523kb -
An economic analysis of strategies to reduce the cost of routine IPV immunization. PATH report 2010
pdf, 370kb